Literature DB >> 998436

Clinical, hemodynamic and metabolic effects of intraarterial infusions of prostaglandin E1 in patients with peripheral vascular disease.

A G Olsson, L A Carlson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 998436

Source DB:  PubMed          Journal:  Adv Prostaglandin Thromboxane Res        ISSN： 0361-5952


× No keyword cloud information.
  5 in total

1.  Treatment of postherpetic neuralgia with prostaglandin E1 ointment a preliminary study.

Authors:  J Shirakawa; Y Kimura; Y Horikawa; H Obara
Journal:  J Anesth       Date:  1992-01       Impact factor: 2.078

2.  Long-term improvement in left ventricular ejection fraction during continuous PGE1-therapy in a patient with congestive cardiomyopathy.

Authors:  H Sinzinger; J O'Grady; W Rogatti
Journal:  Postgrad Med J       Date:  1988-12       Impact factor: 2.401

3.  Dose proportional pharmacokinetics of alprostadil (prostaglandin E1) in healthy volunteers following intravenous infusion.

Authors:  W Cawello; A Leonhardt; H Schweer; H W Seyberth; R Bonn; A L Lomeli
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

4.  Haemodynamic changes induced by prostacyclin in man.

Authors:  J Szczeklik; A Szczeklik; R Nizankowski
Journal:  Br Heart J       Date:  1980-09

5.  Cardiac and microcirculatory effects of different doses of prostaglandin E1 in man.

Authors:  J H Wilkens; H Wilkens; B Elger; F Cassidy; L Caspary; A Creutzig; J C Frölich
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.